DIBIASE MARY (Chief Operating Officer) sold 13.0% of their position (67.69K shares) of X4 PHARMACEUTICALS, INC on the open market
Open‑market sale worth $38.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/8/2024ACC: 0001628280-24-042542
Officer· Chief Operating Officer
Since Sep 2021
+162.95K
Net shares
Net buyer
$38.3K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
230.65K acquired · 67.69K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+230.65K
Price / share
—
Trade value
—
% of position
79.8%
10/4/2024
289.11K→519.75K
Common Stock
Direct
Shares
−67.69K
Price / share
$0.57
Trade value
$38.33K
% of position
13.0%
10/7/2024
519.75K→452.06K
Total
Net shares
+162.95K
Net value
-$38.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/4/2024 | A · Award | +230.65K | — | — | 79.8% | 289.11K | 519.75K |
| Common Stock Direct | 10/7/2024 | S · Sale | −67.69K | $0.57 | $38.33K | 13.0% | 519.75K | 452.06K |
| Total | +162.95K | -$38.33K | ||||||
Derivative Transactions0
No derivative transactions reported